These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34616698)

  • 1. Population Pharmacokinetics Modeling of Vancomycin Among Chinese Infants With Normal and Augmented Renal Function.
    Li DY; Li L; Li GZ; Hu YH; Guo HL; Jing X; Chen F; Ji X; Xu J; Dai HR
    Front Pediatr; 2021; 9():713588. PubMed ID: 34616698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Vancomycin Clearance Between Augmented Renal Clearance and Normal Renal Function in Critically Ill Infants: A Population Pharmacokinetics Study.
    Huang GM; Qiu Y; Liu TT; Lu JJ
    J Clin Pharmacol; 2022 Jul; 62(7):863-872. PubMed ID: 35049078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmented Renal Clearance Using Population-Based Pharmacokinetic Modeling in Critically Ill Pediatric Patients.
    Avedissian SN; Bradley E; Zhang D; Bradley JS; Nazer LH; Tran TM; Nguyen A; Le J
    Pediatr Crit Care Med; 2017 Sep; 18(9):e388-e394. PubMed ID: 28640009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetic model of vancomycin in postoperative neurosurgical patients.
    Wei S; Zhang D; Zhao Z; Mei S
    Front Pharmacol; 2022; 13():1005791. PubMed ID: 36225566
    [No Abstract]   [Full Text] [Related]  

  • 5. A Population Pharmacokinetic Analysis to Study the Effect of Therapeutic Hypothermia on Vancomycin Disposition in Children Resuscitated From Cardiac Arrest.
    Zane NR; Reedy MD; Gastonguay MR; Himebauch AS; Ramsey EZ; Topjian AA; Zuppa AF
    Pediatr Crit Care Med; 2017 Jul; 18(7):e290-e297. PubMed ID: 28481829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.
    Anderson BJ; Allegaert K; Van den Anker JN; Cossey V; Holford NH
    Br J Clin Pharmacol; 2007 Jan; 63(1):75-84. PubMed ID: 16869817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population pharmacokinetic model for individualised dosage regimens of vancomycin in Chinese neonates and young infants.
    Song L; He CY; Yin NG; Liu F; Jia YT; Liu Y
    Oncotarget; 2017 Dec; 8(62):105211-105221. PubMed ID: 29285245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new population pharmacokinetic model for vancomycin in patients with variable renal function: Therapeutic drug monitoring based on extended covariate model using CKD-EPI estimation.
    Kim DJ; Lee DH; Ahn S; Jung J; Kiem S; Kim SW; Shin JG
    J Clin Pharm Ther; 2019 Oct; 44(5):750-759. PubMed ID: 31228353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A population pharmacokinetic model of vancomycin for dose individualization based on serum cystatin C as a marker of renal function.
    Liu TT; Pang HM; Jing L; Wei WX; Qin XL; Guo Q; Lu H; Cheng DH; Jiang WZ
    J Pharm Pharmacol; 2019 Jun; 71(6):945-955. PubMed ID: 30873627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of machine learning combined with population pharmacokinetics to improve individual prediction of vancomycin clearance in simulated adult patients.
    Li G; Sun Y; Zhu L
    Front Pharmacol; 2024; 15():1352113. PubMed ID: 38562463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling Kinetic Glomerular Filtration Rate in Adults with Stable and Unstable Kidney Function: Vancomycin as the Motivating Example.
    Pai MP; DeBacker KC
    Pharmacotherapy; 2020 Sep; 40(9):872-879. PubMed ID: 32640054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal Function Descriptors in Neonates: Which Creatinine-Based Formula Best Describes Vancomycin Clearance?
    Bhongsatiern J; Stockmann C; Yu T; Constance JE; Moorthy G; Spigarelli MG; Desai PB; Sherwin CM
    J Clin Pharmacol; 2016 May; 56(5):528-40. PubMed ID: 26412385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Pharmacokinetics of Vancomycin in Critically Ill Children.
    Sridharan K; Al Daylami A; Ajjawi R; Al-Ajooz H; Veeramuthu S
    Eur J Drug Metab Pharmacokinet; 2019 Dec; 44(6):807-816. PubMed ID: 31301023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of tacrolimus in pediatric refractory nephrotic syndrome and a summary of other pediatric disease models.
    Wang D; Lu J; Li Q; Li Z
    Exp Ther Med; 2019 May; 17(5):4023-4031. PubMed ID: 31007740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first study in pediatric: Population pharmacokinetics of sirolimus and its application in Chinese children with immune cytopenia.
    Cheng X; Zhao Y; Gu H; Zhao L; Zang Y; Wang X; Wu R
    Int J Immunopathol Pharmacol; 2020; 34():2058738420934936. PubMed ID: 32720540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Vancomycin Dose Individualization Strategy by Bayesian Prediction in Patients Receiving Continuous Renal Replacement Therapy.
    Oda K; Jono H; Kamohara H; Nishi K; Tanoue N; Saito H
    Pharm Res; 2020 May; 37(6):108. PubMed ID: 32468340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children with Normal and Augmented Renal Clearance.
    Béranger A; Benaboud S; Urien S; Moulin F; Bille E; Lesage F; Zheng Y; Genuini M; Gana I; Renolleau S; Hirt D; Tréluyer JM; Oualha M
    Clin Pharmacokinet; 2019 Feb; 58(2):223-233. PubMed ID: 29862466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Bayesian predictability of vancomycin concentration using population pharmacokinetic parameters in pediatric patients.
    Ohnishi A; Yano Y; Ishibashi T; Katsube T; Oguma T
    Drug Metab Pharmacokinet; 2005 Dec; 20(6):415-22. PubMed ID: 16415526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of Amisulpride in Chinese patients with schizophrenia with external validation: the impact of renal function.
    Li A; Mak WY; Ruan T; Dong F; Zheng N; Gu M; Guo W; Zhang J; Cheng H; Ruan C; Shi Y; Zang Y; Zhu X; He Q; Xiang X; Wang G; Zhu X
    Front Pharmacol; 2023; 14():1215065. PubMed ID: 37731733
    [No Abstract]   [Full Text] [Related]  

  • 20. How Much Vancomycin Dose Is Enough For The MRSA Infection in Pediatric Patients With Various Degrees of Renal Function?
    Wang Y; Gao P; Zhang H; Chen Y; Niu C; Liu M; Li S; Xu Q; Ye Q
    Iran J Pharm Res; 2019; 18(2):995-1009. PubMed ID: 31531080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.